Research Article
Correlation of Triiodothyronine Level with In-Hospital Cardiac Function and Long-Term Prognosis in Patients with Acute Myocardial Infarction
Table 2
Basic characteristics based on FT3 levels in AMI patients.
| | Free triiodothyronine levels (pmol/L) | value | 1.62–3.98 | 3.99–5.33 | 5.34–8.55 |
| Female (%) | 18.35% | 18.35% | 22.94% | | GRACE score | 116.098 ± 43.037 | 121.991 ± 40.497 | 128.117 ± 38.421 | 0.091 | Age (y) | 59.625 ± 10.468 | 58.351 ± 10.107 | 59.694 ± 10.490 | 0.550 | HR (bpm) | 69.732 ± 14.248 | 72.728 ± 22.362 | 69.856 ± 13.955 | 0.344 | Onset of AMI (h) | 17.538 ± 32.545 | 17.769 ± 30.339 | 16.692 ± 18.481 | 0.911 | CKMB (U/L) | 40.333 ± 66.052 | 40.266 ± 61.909 | 41.398 ± 60.269 | 0.989 | HbA1C (%) | 124.027 ± 19.070 | 124.513 ± 18.211 | 125.973 ± 16.001 | 0.272 | sBP (mmHg) | 76.929 ± 11.943 | 78.796 ± 11.498 | 78.369 ± 11.353 | 0.700 | dBP (mmHg) | 5.693 ± 0.356 | 5.744 ± 0.357 | 5.767 ± 0.328 | 0.454 | EF (%) | 67.939 ± 14.945 | 69.152 ± 16.936 | 69.203 ± 14.298 | <0.001 | AST (U/L) | 55.486 ± 13.468 | 60.057 ± 11.187 | 62.135 ± 11.974 | <0.05 | Creatine (μmol/L) | 68.437 ± 75.677 | 53.158 ± 57.580 | 40.438 ± 45.711 | 0.192 | NT-proBNP (pg/mL) | 1780.395 ± 3700.982 | 739.469 ± 1208.398 | 411.908 ± 537.265 | <0.001 | T4 (μg/dL) | 6.464 ± 1.641 | 7.005 ± 1.687 | 7.911 ± 1.875 | <0.001 | T3 (ng/mL) | 0.845 ± 0.238 | 1.015 ± 0.277 | 1.218 ± 0.286 | <0.001 | FT4 (pmol/L) | 13.432 ± 2.918 | 14.832 ± 2.836 | 16.540 ± 3.075 | <0.001 | FT3 (pmol/L) | 3.336 ± 0.512 | 4.690 ± 0.394 | 6.295 ± 0.750 | <0.001 | TSH (μIU/mL) | 2.812 ± 7.305 | 2.238 ± 3.348 | 2.241 ± 1.618 | 0.585 | TGAB (%) | 8.873 ± 12.438 | 6.765 ± 9.865 | 8.271 ± 10.397 | 0.335 | TMAB (%) | 6.567 ± 8.205 | 5.184 ± 6.313 | 6.202 ± 7.025 | 335.000 | Previous history of hypertension (%) | 44.95% | 50.46% | 54.13% | | CHF (%) | 6.42% | 1.83% | 1.83% | | Myocardial infarction (%) PCI or CABG (%) | 13.76% | 13.76% | 14.68% | | In-hospital treatment | 18.35% | 16.51% | 20.18% | | Aspirin (%) | 95.41% | 97.25% | 97.25% | | β-Blocker (%) | 78.90% | 88.99% | 80.73% | | Statin (%) | 97.25% | 99.08% | 92.66% | | CCB (%) | 15.60% | 19.27% | 15.60% | |
|
|
Abbreviations: GRACE: the Global Registry of Acute Coronary Events; HR: heart rate; CKMB: MB isoenzyme of creatine kinase; HbA1c: hemoglobin A1c; BP: blood pressure; EF: ejection fraction; AST: aspartate transaminase; NT-proBNP: probrain natriuretic peptide; T4: thyroxine; T3: triiodothyronine; FT4: free thyroxine; FT3: free triiodothyronine; TSH: thyroid-stimulating hormone; TGAB: thyroglobulin; TMAB: thyroid microsomal antibody; CHF: chronic heart failure; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; CCB: calcium channel blocker. Data are mean ± SD and number (%).
|